A First-in-Human Study of HLA-Partially to Fully Matched Allogeneic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients with Hematologic Malignancies | Synapse
March 3, 2026
A First-in-Human Study of HLA-Partially to Fully Matched Allogeneic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients with Hematologic Malignancies
Key Points
Bone marrow transplantation showed promising outcomes for patients with hematologic malignancies.
The study targets HLA-partially to fully matched donors with significant improvements in transplant success.
Assessment of deceased donor bone marrow transplantation provides new insights into treatment modalities.
Findings highlight the need for continued exploration of allogeneic transplant strategies.